W19-039: Assessment Of Transdermal Penetration Of Gabapentin In Cats
Little is known about the therapeutic potential of gabapentin administered via the transdermal route in cats. Therefore, the goal of
Little is known about the therapeutic potential of gabapentin administered via the transdermal route in cats. Therefore, the goal of
Amyloidosis is a term referred to a group of diseases caused by the abnormal deposition of insoluble proteins (amyloid) in
Amyloidosis is a disease caused by abnormal insoluble protein deposits accumulating in the organs, leading to death from liver or
Sequencing of the cat genome has resulted in numerous breakthroughs in the understanding of feline genetic disease. DNA from the